Nucleic Acids Research, Vol 26, Issue 19 4524-4528, Copyright © 1998 by Oxford University Press
T Schluep and CL Cooney
Production of pharmaceutical grade plasmid DNA is an important issue in
gene therapy. We developed a method for affinity purification of plasmids
by triple helix interaction. This method is based on sequence- specific
binding of an oligonucleotide immobilized on a large pore chromatography
support to a target sequence on the plasmid. Using design criteria derived
from thermodynamic data, we produced a 15mer target sequence which binds
strongly to the affinity support under mildly acidic conditions. Plasmid
DNA was purified from clarified Escherichia coli lysate by incubation with
the affinity beads at pH 5.0 and high NaCl concentration. After extensive
washing of the beads, purified plasmid DNA was eluted with alkaline buffer.
The purified plasmid showed no RNA or cell DNA contamination in HPLC
analysis and total protein concentration was reduced considerably. Due to
its mechanical stability and porosity this support can be used in a
continuous affinity purification process, which has a high potential for
scale up.
ARTICLES
Purification of plasmids by triplex affinity interaction
Chemical Engineering Department, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. thomas.schluep@canji.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Duca, P. Vekhoff, K. Oussedik, L. Halby, and P. B. Arimondo The triple helix: 50 years later, the outcome Nucleic Acids Res., September 1, 2008; 36(16): 5123 - 5138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Escude, T. Garestier, and C. Helene Padlock oligonucleotides for duplex DNA based on sequence-specific triple helix formation PNAS, September 14, 1999; 96(19): 10603 - 10607. [Abstract] [Full Text] [PDF] |
||||

